Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements


Download results of this page


Refine by:

Content type

Project (85)

Advanced search

Search projects and results

Results 1 - 10 of 85
Results/page:
12 3 4 5 6 7 8 9 > 
Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes
ID: 115890
Start date: 2015-07-01, End date: 2017-12-31
Progress in the life sciences and related technologies offer great potential for therapeutic benefits to patients in need. However, major adaptations to current paradigms of bringing medicines to patients are required in order to realize that potential and to address important...
Programme: H2020-EU.3.1.7.13.
Record Number: 209455
Last updated on: 2017-03-27
Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes.
ID: 115797
Start date: 2015-11-01, End date: 2022-10-31
Preclinical type 1 diabetes (T1D) research has made important advances in recent years, but less progress has been made in translating findings from in vitro and animal models into effective clinical interventions. INNODIA aims to achieve a break-through in the way in which we...
Programme: H2020-EU.3.1.7.4.
Record Number: 209863
Last updated on: 2017-03-27
Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation (DO->IT)
ID: 116055
Start date: 2017-02-01, End date: 2019-01-31
The overall goal of the Big Data for Better Outcomes (BD4BO) programme is to facilitate the use of ‘big data’ to promote the development of value-based, outcomes-focused healthcare systems in Europe. To fully exploit the transformative potential of big data, consideration...
Programme: H2020-EU.3.1.
Record Number: 209468
Last updated on: 2017-03-27
REspiratory Syncytial virus Consortium in EUrope
ID: 116019
Start date: 2017-01-01, End date: 2021-12-31
RSV causes severe disease and results in substantial healthcare costs in individuals at the extremes of the age spectrum and in high risk groups. RESCEU brings together academia, national public health agencies and EFPIA with proven expertise and a strong track record in RSV...
Programme: H2020-EU.3.1.
Record Number: 209463
Last updated on: 2017-03-27
Biomarker Enterprise to Attack DKD
[PROJECT] BEAt-DKD - Biomarker Enterprise to Attack DKD
ID: 115974
Start date: 2016-09-01, End date: 2021-08-31
Diabetic kidney disease (DKD) is the leading cause of end stage renal disease (ESRD), and its global incidence and prevalence have reached epidemic dimensions in recent years. Unfortunately, there are no effective means to prevent or cure DKD. Apart from...
Programme: H2020-EU.3.1.7.
Record Number: 209459
Last updated on: 2017-03-27
Communication strategy and tools for optimizing the impact of Ebola vaccination deployment.
ID: 115847
Start date: 2014-12-01, End date: 2019-11-30
Communication strategy and tools for optimizing the impact of Ebola vaccination deployment.The EBODAC consortium consists of 4 partners: Janssen (EFPIA), London School of Hygiene and Tropical Medicine (LSHTM), World Vision of Ireland and Grameen Foundation . These partners...
Programme: H2020-EU.3.1.7.13.
Record Number: 209447
Last updated on: 2017-03-27
Global material flows and demand-supply forecasting for mineral strategies
ID: 730330
Start date: 2016-12-01, End date: 2018-11-30
Global demand for minerals is growing rapidly, driven by rapid population growth, urbanisation and an increasingly diverse range of technical applications. Global material supply chains linking the extraction, transport and processing stages of raw materials have become...
Programme: H2020-EU.3.5.3.
Record Number: 206335
Last updated on: 2017-05-04
Remote Assessment of Disease and Relapse in Central Nervous System Disorders
ID: 115902
Start date: 2016-04-01, End date: 2021-03-31
Background: Long term conditions require monitoring of patients, traditionally conducted in the clinic, to monitor treatment effects, adverse events and disease course. This can be inefficient and cumbersome – clinic visits may be too infrequent to identify individuals at...
Programme: H2020-EU.3.1.7.13.
Record Number: 209453
Last updated on: 2017-05-23
Vaccine safety and immunogenicity signatures of human responses to VSV-ZEBOV
ID: 115842
Start date: 2015-03-01, End date: 2018-02-28
The proposal, VSV-EBOVAC, directly addresses the topic 1 of the IMI2 call on Ebola by supporting the clinical development of a highly promising new Ebola vaccine candidate, the vesicular stomatitis virus (VSV)‐ vectored Zaire Ebola vaccine (VSV-ZEBOV). In non-human primates...
Programme: H2020-EU.3.1.7.13.
Record Number: 209443
Last updated on: 2017-06-10
SYSTEMS ANALYSIS OF ADULT AND PEDIATRIC RESPONSES TO THE VSV-ZEBOV EBOLA VACCINE
ID: 116068
Start date: 2016-04-01, End date: 2021-03-31
The vesicular stomatitis virus (VSV)-Zaire Ebola vaccine (VSV-ZEBOV) is a recombinant vector-based vaccine in which the VSV envelope glycoprotein was replaced with the Zaire strain Ebola virus glycoprotein. Within one year of the initiation of its clinical development, the...
Programme: H2020-EU.3.1.
Record Number: 211191
Last updated on: 2017-06-16
12 3 4 5 6 7 8 9 > 
List retrieved on: 2018-01-21
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top